127 related articles for article (PubMed ID: 35916339)
1. Targeting FHL1 impairs cell proliferation and differentiation of acute myeloid leukemia cells.
Liu Y; Li H; Zhao Y; Li D; Zhang Q; Fu J; Fan S
Biochem Cell Biol; 2022 Aug; 100(4):301-308. PubMed ID: 35916339
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide identification of FHL1 as a powerful prognostic candidate and potential therapeutic target in acute myeloid leukaemia.
Fu Y; Xu M; Cui Z; Yang Z; Zhang Z; Yin X; Huang X; Zhou M; Wang X; Chen C
EBioMedicine; 2020 Feb; 52():102664. PubMed ID: 32062360
[TBL] [Abstract][Full Text] [Related]
3. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
Wei X; Zhang H
Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
[TBL] [Abstract][Full Text] [Related]
4. FHL1 inhibits the growth of tongue squamous cell carcinoma cells via G1/S cell cycle arrest.
Ren W; Lian P; Cheng L; Du P; Guan X; Wang H; Ding L; Gao Z; Huang X; Xiao F; Wang L; Bi X; Ye Q; Wang E
Mol Med Rep; 2015 Sep; 12(3):3958-3964. PubMed ID: 26017856
[TBL] [Abstract][Full Text] [Related]
5. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity.
Luo Q; Pan Y; Fu Q; Zhang X; Zhou S; Yu P; Tian H; Liu P; Chen S; Zhang H; Qin T
Cell Biol Toxicol; 2023 Oct; 39(5):2069-2087. PubMed ID: 35142956
[TBL] [Abstract][Full Text] [Related]
6. X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma.
Cao W; Liu J; Xia R; Lin L; Wang X; Xiao M; Zhang C; Li J; Ji T; Chen W
Oncotarget; 2016 Mar; 7(12):14537-50. PubMed ID: 26908444
[TBL] [Abstract][Full Text] [Related]
7. FHL1 and Smad4 synergistically inhibit vascular endothelial growth factor expression.
Zhou Z; Lu J; Dou J; Lv Z; Qin X; Lin J
Mol Med Rep; 2013 Feb; 7(2):649-53. PubMed ID: 23184087
[TBL] [Abstract][Full Text] [Related]
8. MiR-96-5p Induced by Palmitic Acid Suppresses the Myogenic Differentiation of C2C12 Myoblasts by Targeting FHL1.
Nguyen MT; Min KH; Lee W
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322515
[TBL] [Abstract][Full Text] [Related]
9. Estrogen enhances activity of Wnt signaling during osteogenesis by inducing Fhl1 expression.
Wu SM; Shih LH; Lee JY; Shen YJ; Lee HH
J Cell Biochem; 2015 Jul; 116(7):1419-30. PubMed ID: 25676585
[TBL] [Abstract][Full Text] [Related]
10. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells.
Huang Q; Wang L; Ran Q; Wang J; Wang C; He H; Li L; Qi H
Drug Des Devel Ther; 2019; 13():1927-1940. PubMed ID: 31239643
[No Abstract] [Full Text] [Related]
11. Inhibition of FHL1 inhibits cigarette smoke extract-induced proliferation in pulmonary arterial smooth muscle cells.
Li Y; Pu G; Chen C; Yang L
Mol Med Rep; 2015 Sep; 12(3):3801-3808. PubMed ID: 25975448
[TBL] [Abstract][Full Text] [Related]
12. MiR-183-5p induced by saturated fatty acids regulates the myogenic differentiation by directly targeting FHL1 in C2C12 myoblasts.
Nguyen MT; Min KH; Lee W
BMB Rep; 2020 Nov; 53(11):605-610. PubMed ID: 33148375
[TBL] [Abstract][Full Text] [Related]
13. Four-and-a-half LIM protein 1 promotes paclitaxel resistance in hepatic carcinoma cells through the regulation of caspase-3 activation.
Zhou L; Ding L; Liu J; Zhang Y; Luo X; Zhao L; Ren J
J Cancer Res Ther; 2018 Sep; 14(Supplement):S767-S773. PubMed ID: 30249901
[TBL] [Abstract][Full Text] [Related]
14. Expression of FHL1 in gastric cancer tissue and its correlation with the invasion and metastasis of gastric cancer.
Xu Y; Liu Z; Guo K
Mol Cell Biochem; 2012 Apr; 363(1-2):93-9. PubMed ID: 22143536
[TBL] [Abstract][Full Text] [Related]
15. [FHL1 knockdown mediated by lentiviral shRNA promotes the growth of HeLa and HepG2 cells].
Fan Z; Xu X; Zhang X; Wang T; Han B; Liang Y; Ye Q; Jiao S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):879-83. PubMed ID: 26146054
[TBL] [Abstract][Full Text] [Related]
16. FHL1 promotes glioblastoma aggressiveness through regulating EGFR expression.
Sun L; Chen L; Zhu H; Li Y; Chen CC; Li M
FEBS Lett; 2021 Jan; 595(1):85-98. PubMed ID: 33053208
[TBL] [Abstract][Full Text] [Related]
17. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.
Domenighetti AA; Chu PH; Wu T; Sheikh F; Gokhin DS; Guo LT; Cui Z; Peter AK; Christodoulou DC; Parfenov MG; Gorham JM; Li DY; Banerjee I; Lai X; Witzmann FA; Seidman CE; Seidman JG; Gomes AV; Shelton GD; Lieber RL; Chen J
Hum Mol Genet; 2014 Jan; 23(1):209-25. PubMed ID: 23975679
[TBL] [Abstract][Full Text] [Related]
18. FHL1 mutants that cause clinically distinct human myopathies form protein aggregates and impair myoblast differentiation.
Wilding BR; McGrath MJ; Bonne G; Mitchell CA
J Cell Sci; 2014 May; 127(Pt 10):2269-81. PubMed ID: 24634512
[TBL] [Abstract][Full Text] [Related]
19. Fhl1 W122S causes loss of protein function and late-onset mild myopathy.
Emmanuele V; Kubota A; Garcia-Diaz B; Garone C; Akman HO; Sánchez-Gutiérrez D; Escudero LM; Kariya S; Homma S; Tanji K; Quinzii CM; Hirano M
Hum Mol Genet; 2015 Feb; 24(3):714-26. PubMed ID: 25274776
[TBL] [Abstract][Full Text] [Related]
20. CpG hypermethylation of human four-and-a-half LIM domains 1 contributes to migration and invasion activity of human bladder cancer.
Matsumoto M; Kawakami K; Enokida H; Toki K; Matsuda R; Chiyomaru T; Nishiyama K; Kawahara K; Seki N; Nakagawa M
Int J Mol Med; 2010 Aug; 26(2):241-7. PubMed ID: 20596604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
